These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 21293107

  • 1. Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial.
    Langley RG, Gupta A, Papp K, Wexler D, Østerdal ML, Curčić D.
    Dermatology; 2011; 222(2):148-56. PubMed ID: 21293107
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
    Ortonne JP, Kaufmann R, Lecha M, Goodfield M.
    Dermatology; 2004; 209(4):308-13. PubMed ID: 15539894
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
    Peeters P, Ortonne JP, Sitbon R, Guignard E.
    Dermatology; 2005 Jun; 211(2):139-45. PubMed ID: 16088161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL.
    Drugs; 2011 Apr 16; 71(6):709-30. PubMed ID: 21504248
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
    Calzavara-Pinton P, Rossi MT, Sala R, Venturini M.
    G Ital Dermatol Venereol; 2011 Aug 16; 146(4):295-9. PubMed ID: 21785396
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul 16; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 12. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
    Kragballe K, van de Kerkhof P.
    J Eur Acad Dermatol Venereol; 2014 May 16; 28 Suppl 2():10-21. PubMed ID: 24684739
    [Abstract] [Full Text] [Related]

  • 13. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A, Gold LS, Bukhalo M, Grekin S, Kempers S, Boyce BM, Ganslandt C, Villumsen J, Lebwohl M.
    J Drugs Dermatol; 2013 Jan 16; 12(1):92-8. PubMed ID: 23377334
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A, Chimenti S.
    J Dermatolog Treat; 2007 Jan 16; 18(6):361-5. PubMed ID: 17934937
    [Abstract] [Full Text] [Related]

  • 15. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y.
    Skin Therapy Lett; 2002 Jun 16; 7(6):1-3. PubMed ID: 12223976
    [Abstract] [Full Text] [Related]

  • 16. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC.
    Skin Therapy Lett; 2009 May 16; 14(4):1-4. PubMed ID: 19585059
    [Abstract] [Full Text] [Related]

  • 17. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 May 16; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 18. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.
    Br J Dermatol; 2006 Jun 16; 154(6):1155-60. PubMed ID: 16704648
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW, Houwing R, Sindrup JH, Wigchert S.
    Eur J Dermatol; 2009 Jun 16; 19(6):581-5. PubMed ID: 19726275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.